The breast implants market, with a 7.53% CAGR, is projected to rise from USD 2.912 billion in 2025 to USD 4.501 billion in 2031.
Breast implants are medical devices used to enhance the size and shape of a woman's breasts through surgical procedures. They are primarily used for cosmetic purposes. The rising prevalence of breast cancer, along with the increasing beauty consciousness and awareness about breast reconstruction, is expected to boost the breast implants market. Moreover, technological advancements in the implant system and rising disposable income are further expected to aid the breast implants market.
Rising Prevalence of Breast Cancer
Breast implants are commonly used in breast reconstruction procedures after mastectomy (surgical removal of one or both breasts) due to breast cancer. Therefore, the rising cases of breast cancer are expected to propel the breast implants market. Breast cancer is the most prevalent cancer of all types around the globe. For instance, there were around 2.3 million new instances of breast cancer in 2020, and there were approximately 685 000 deaths from the condition in the world as per the International Agency for Research on Cancer (IARC). Moreover, it is estimated by the IARC that there will be more than 3 million new instances of breast cancer annually (an increase of 40%) and more than 1 million annual fatalities (an increase of 50%) by 2040.
Increasing Beauty Consciousness
In recent years, there has been a growing trend of people seeking cosmetic enhancements to improve their physical appearance. The increasing emphasis on beauty and body image in society has driven the breast implants market. For instance, according to the 2023 annual Global Survey on Aesthetic/Cosmetic Procedures conducted by the International Society of Aesthetic Plastic Surgery (ISAPS), plastic surgeons worldwide reported a significant increase of 19.3% in overall procedures performed in 2021. The survey revealed that more than 12.8 million surgical procedures and approximately 17.5 million non-surgical procedures were conducted globally during that year. Moreover, breast augmentation was the most common surgical procedure for women according to the same survey.
Advancements in Implant Technology
Technological innovations in breast implant materials and design have improved the safety, durability, and natural appearance of implants. Advancements in implant surfaces, such as textured implants, have helped reduce the risk of implant rotation and capsular contracture, thereby propelling the breast implants market. For example, modern breast implants often use cohesive silicone gel, which maintains its shape and integrity even if the implant shell is compromised. Nanotechnology has influenced breast implant development by creating nanostructured surfaces that enhance tissue integration and reduce complications like capsular contracture. Moreover, advanced 3D imaging and simulation technologies allow patients to visualize potential outcomes before undergoing surgery and thus help in improved decision-making.
Rising Disposable Income
Economic prosperity and increasing disposable income in various regions have allowed more individuals to afford cosmetic procedures, making breast implants more accessible to a broader demographic. Therefore, rising disposable income is expected to bolster the breast implants market. For instance, according to the Ministry of Statistics and Program Implementation, the gross disposable income of India witnessed a growth of 6.4% in the fiscal year 2019-20, reaching a total of Rs. 204.22 lakh crore. Moreover, according to the data from the National Bureau of Statistics, China's per capita disposable income was 35,128 yuan (about $5,523) in 2021, an increase of 9.1% year over year in nominal terms.
Restraints in the Market
The breast implants market has experienced growth and development; however, some restraints or challenges can impact its expansion. For example, the cost of the implants themselves, the surgeon's fees, the anesthesia, and the post-operative care may all add up to a significant expense for breast implant treatments. Therefore, affordability might be a limiting factor for some people, which may negatively impact the market expansion. Issues such as implant rupture, capsular contracture, implant-associated anaplastic large cell lymphoma (BIA-ALCL), and potential long-term health effects have raised questions about the safety profile of breast implants. These concerns have led to increased scrutiny by health authorities and regulatory bodies, thereby potentially affecting consumer confidence and market demand.
North America is Expected to Grow Significantly
North America is expected to hold a significant share of the breast implants market during the forecast period. The factors attributed to such a share are rising breast cancer cases, increasing disposable income, a strong healthcare system, and earlier adoption of technological advancements. For instance, breast cancer is the second-highest diagnosed cancer in the USA, contributing to around 30% of all new female cancers each year, according to the American Cancer Society. Moreover, breast augmentation is one of the top 5 surgical procedures in America, as per the American Society of Plastic Surgeons 2020 report.
Polytech Health & Aesthetics GmbH is a German company specializing in the development and manufacturing of medical devices, particularly breast implants and products for plastic and reconstructive surgery. Polytech Patient Pathway™ and B-Lite® lightweight implants are offered by the company for breast implants.
Motiva Implants is a brand of breast implants known for its focus on innovation, safety, and patient-centered design. Motiva offers a range of ergonomic gel-filled breast implants called Ergonomix. These implants were designed to adapt to the patient's movements and provide a more natural appearance.
Groupe Sebbin SAS is a French company specializing in the development, manufacturing, and distribution of medical devices, particularly breast implants and products for plastic and reconstructive surgery. The breast implant solutions offered by the company are Sensity, Volupty, Purity, and Integrity.
December 2025: Establishment Labs submitted Motiva® breast implants to the U.S. FDA for approval in primary and revision breast reconstruction, building on prior augmentation clearances and clinical experience.
October 2025: Allergan Aesthetics’ Natrelle® breast implant portfolio was named a supplier with Vizient, expanding access across major U.S. hospitals and healthcare networks with over 300 implant options.
October 2025: Establishment Labs published its 2025 Post-Market Surveillance Report with 15 years of Motiva® implant data showing consistent real-world performance and low complication rates across global use.
August 2025: Allergan Aesthetics launched the “Faces of Natrelle®” campaign to spotlight real patient experiences and support patient education on breast augmentation and reconstruction choices.
May 2025: Johnson & Johnson MedTech launched MENTOR™ MemoryGel™ Enhanced breast implants in the U.S., offering FDA-approved larger-volume options (930–1445 cc) to broaden personalized reconstruction outcomes for post-mastectomy patients.
ALLERGAN (ABBVIE INC.)
GC Aesthetics
GROUPE SEBBIN SAS
J&J MedTech
Sientra Inc.
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Companies |
|
Report Metric | Details |
Breast Implants Market Size in 2025 | USD 2.912 billion |
Breast Implants Market Size in 2030 | USD 4.232 billion |
Growth Rate | CAGR of 7.76% |
Study Period | 2020 to 2030 |
Historical Data | 2020 to 2023 |
Base Year | 2024 |
Forecast Period | 2025 – 2030 |
Forecast Unit (Value) | USD Billion |
Segmentation |
|
Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
List of Major Companies in Breast Implants Market |
|
Customization Scope | Free report customization with purchase |
By Product
Silicone Breast Implants
Saline Breast Implants
By Shape
Round
Anatomical
By Application
Reconstructive Surgery
Cosmetic Surgery
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others